Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

Non-clinical data showed better response compared to the Omicron XBB.1.5-adapted vaccine. The Health Sciences Authority has ...

The news follows recommendations by the European Medicines Agency Emergency Task Force to update COVID-19 vaccines for ... vaccine that targets the Omicron XBB.1.16 SARS-CoV-2 subvariant.

Australian Department of Health statistics showed 72.3 million doses of the COVID-19 vaccine had been administered as of October 9. Pfizer's Omicron XBB. 1.5 and original vaccines were approved ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons.

The CDC has just announced a second shot for elders and the immunocompromised people – but when’s the best time?

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

Prior to Health Canada's latest approval, Canadians had the option to receive a booster of the previous formulation that targets Omicron XBB.1.5. However, these are updated vaccines that replace those ...